Tong Shu

419 total citations
22 papers, 251 citations indexed

About

Tong Shu is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Tong Shu has authored 22 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Reproductive Medicine and 7 papers in Cancer Research. Recurrent topics in Tong Shu's work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Genetic factors in colorectal cancer (3 papers). Tong Shu is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Genetic factors in colorectal cancer (3 papers). Tong Shu collaborates with scholars based in China, Ethiopia and United States. Tong Shu's co-authors include Zhihua Liu, Xiaowei Wu, Pengfei Zhao, Wan Chang, Qingyu Luo, Fang Ding, Yating Wang, Bin Li, Bin Li and Yi Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biophysical Journal and British Journal of Cancer.

In The Last Decade

Tong Shu

19 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tong Shu China 8 174 87 49 37 37 22 251
Jinxiao Liang China 10 218 1.3× 83 1.0× 100 2.0× 33 0.9× 35 0.9× 27 330
Imre Pete Hungary 10 110 0.6× 78 0.9× 58 1.2× 36 1.0× 89 2.4× 22 261
Jitka Hausnerová Czechia 10 142 0.8× 70 0.8× 93 1.9× 24 0.6× 84 2.3× 37 297
Xuan Pei China 8 120 0.7× 142 1.6× 81 1.7× 102 2.8× 23 0.6× 17 311
Yapei Zhu China 11 123 0.7× 63 0.7× 79 1.6× 13 0.4× 57 1.5× 15 284
Chunfang Ha China 9 160 0.9× 76 0.9× 117 2.4× 23 0.6× 84 2.3× 25 308
Cunjian Yi China 9 84 0.5× 44 0.5× 66 1.3× 12 0.3× 30 0.8× 26 194
Koji Nishino Japan 10 113 0.6× 89 1.0× 40 0.8× 68 1.8× 91 2.5× 20 259
Gonghua Qi China 10 157 0.9× 102 1.2× 73 1.5× 57 1.5× 91 2.5× 16 365
Ouping Huang China 11 154 0.9× 34 0.4× 72 1.5× 25 0.7× 113 3.1× 26 317

Countries citing papers authored by Tong Shu

Since Specialization
Citations

This map shows the geographic impact of Tong Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Shu more than expected).

Fields of papers citing papers by Tong Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Shu. The network helps show where Tong Shu may publish in the future.

Co-authorship network of co-authors of Tong Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Tong Shu. A scholar is included among the top collaborators of Tong Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong Shu. Tong Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shu, Tong, Haihui Xin, Pengcheng Zhang, et al.. (2025). Stage Characteristics and Grading Early Warning Method of Coal Spontaneous Combustion Process Based on Coal Structure and Gas Product Increment. Combustion Science and Technology. 1–24.
3.
Liu, Jingwei, Tong Shu, Yulian Mu, et al.. (2025). Curdione combined with borneol treats bacterial mixed HPV infection by regulating the crosstalk among immune cells. Frontiers in Immunology. 16. 1503355–1503355. 1 indexed citations
4.
Guo, Shuling, et al.. (2024). Senescent Fibroblasts Drive FAP/OLN Imbalance Through mTOR Signaling to Exacerbate Inflammation and Bone Resorption in Periodontitis. Advanced Science. 12(7). e2409398–e2409398. 6 indexed citations
5.
Cai, Yan, Tong Shu, & Hong Zheng. (2024). Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer. BMC Women s Health. 24(1). 100–100.
6.
7.
Shu, Tong, Siwen Zhang, T. Sun, et al.. (2024). The prognostic value of tumor-informed minimal residual disease detection using circulating tumor DNA in first-line treatment of ovarian cancer. Gynecologic Oncology. 192. 94–101. 5 indexed citations
8.
Zhang, Nan, et al.. (2023). Real-world study of bevacizumab treatment in patients with ovarian cancer: a Chinese single-institution study of 155 patients. BMC Women s Health. 23(1). 178–178. 5 indexed citations
9.
Xiao, Lu, Qing Li, Tong Shu, et al.. (2023). A deregulated m 6 A writer complex axis driven by BRD4 confers an epitranscriptomic vulnerability in combined DNA repair–targeted therapy. Proceedings of the National Academy of Sciences. 120(41). e2304534120–e2304534120. 5 indexed citations
10.
Zheng, Hong, Tong Shu, Shan Zhu, et al.. (2021). Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian Cancer. Frontiers in Oncology. 11. 725264–725264. 9 indexed citations
11.
Shu, Tong, Dajun Sang, Sarah Tsao, et al.. (2021). Liquid-Liquid Phase Separation is Influenced by the Active, Crowded Cytoplasm. Biophysical Journal. 120(3). 31a–32a. 2 indexed citations
12.
Wu, Xiaowei, Qingyu Luo, Pengfei Zhao, et al.. (2019). JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death and Differentiation. 27(1). 55–70. 54 indexed citations
13.
14.
Wu, Xiaowei, Qingyu Luo, Pengfei Zhao, et al.. (2019). MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer. Proceedings of the National Academy of Sciences. 116(8). 2961–2966. 65 indexed citations
15.
Luo, Qingyu, Xiaowei Wu, Yiping Zhang, et al.. (2018). ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. Cancer Letters. 427. 9–17. 34 indexed citations
16.
Shu, Tong, Yi Li, Xiaowei Wu, Bin Li, & Zhihua Liu. (2017). Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment. Cancer Letters. 411. 65–73. 19 indexed citations
17.
Shu, Tong, Dan Zhao, Bin Li, et al.. (2017). Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years’ experience of National Cancer Center in China. Chinese Journal of Cancer Research. 29(6). 510–520. 24 indexed citations
18.
Feng, Xiaoling, et al.. (2016). [Expression and clinical significance of ELOVL6 gene in high-grade serous ovarian carcinoma].. PubMed. 51(3). 192–7. 3 indexed citations
19.
Shu, Tong, Ping Bai, Rong Zhang, & Shumin Li. (2014). [Clinical analysis and prognostic factors in 106 patients with stage Ia-IIb cervical cancer with pulmonary metastasis].. PubMed. 36(9). 703–7. 7 indexed citations
20.
Liu, Ju, et al.. (2014). Risk of Malignancy Associated with a Maternal Family History of Cancer. Asian Pacific Journal of Cancer Prevention. 15(5). 2039–2044. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxiao Liang Breakdown of academic impact, for papers by Imre Pete Breakdown of academic impact, for papers by Jitka Hausnerová Breakdown of academic impact, for papers by Xuan Pei Breakdown of academic impact, for papers by Yapei Zhu Breakdown of academic impact, for papers by Chunfang Ha Breakdown of academic impact, for papers by Cunjian Yi Breakdown of academic impact, for papers by Koji Nishino Breakdown of academic impact, for papers by Gonghua Qi Breakdown of academic impact, for papers by Ouping Huang
Rankless by CCL
2026